Mineralys Therapeutics Inc (NASDAQ:MLYS) stock surged 7.9% after reporting positive topline data from its Phase 2 Explore-CKD trial for lorundrostat in patients with hypertension and chronic kidney ...

Surgery Partners, Inc. (NASDAQ: SGRY) stock fell 12% after the company announced it has concluded discussions with Bain Capital regarding a potential acquisition.

Investing.com -- UBS Global Research has reiterated a neutral stance on U.K. equities, citing weak earnings growth, currency pressures, and heightened near-term economic uncertainty. Despite a more ...

Investing.com -- Dyne Therapeutics, Inc. (Nasdaq:DYN) stock fell 23% after the company announced an updated plan for obtaining U.S. Accelerated Approval for DYNE-101 in myotonic dystrophy type 1 (DM1) ...

Kraft Heinz stated that for the small portion of products currently containing artificial colors, it plans to remove the dyes where they are not critical or replace them with natural colors. The ...

Immuneering Corporation (NASDAQ:IMRX) stock rose 7% on Monday after the clinical-stage oncology company reported positive survival data from its ongoing Phase 2a trial evaluating atebimetinib in ...